During the past decade, Azienda Ospedaliera Citta della Salute e della Scienza di Torino conducted 424 clinical trials. In the 10-year time frame, 424 clinical trials started and 132 clinical trials were completed, i.e. on average, 31.1% percent of trials that started reached the finish line to date. In the past 5 years, 198 clinical trials started and 88 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera Citta della Salute e della Scienza di Torino" #1 sponsor was "Hoffmann-La Roche" with 47 trials, followed by "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 44 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 36 trials sponsored, "Janssen Research & Development, LLC" with 27 trials sponsored and "Azienda Ospedaliera Città della Salute e della Scienza di Torino" with 27 trials sponsored. Other sponsors include 434 different institutions and companies that sponsored additional 202 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera Citta della Salute e della Scienza di Torino" #1 collaborator was "Eli Lilly and Company" with 8 trials as a collaborator, "AbbVie" with 6 trials as a collaborator, "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 5 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials as a collaborator and "ICON plc" with 4 trials as a collaborator. Other collaborators include 274 different institutions and companies that were collaborators in the rest 227 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera Citta della Salute e della Scienza di Torino" are "Multiple Myeloma" (41 trials), "Chronic Lymphocytic Leukemia" (18 trials), "Breast Cancer" (17 trials), "Acute Myeloid Leukemia" (14 trials) and "Leukemia" (11 trials). Many other conditions were trialed in "Azienda Ospedaliera Citta della Salute e della Scienza di Torino" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera Citta della Salute e della Scienza di Torino" are "Drug" (408 trials), "Other" (67 trials), "Procedure" (46 trials), "Biological" (38 trials) and "Device" (34 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (81 trials), "Rituximab" (30 trials), "Dexamethasone" (23 trials), "Cyclophosphamide" (15 trials) and "Prednisone" (13 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera Citta della Salute e della Scienza di Torino" are 578 trials for "All" genders, 26 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are 228 active trials in "Azienda Ospedaliera Citta della Salute e della Scienza di Torino". 3 are not yet recruiting, 120 are recruiting, 101 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 266 completed trials in Azienda Ospedaliera Citta della Salute e della Scienza di Torino, undefined suspended trials, and 52 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera Citta della Salute e della Scienza di Torino, 34 "Phase 1" clinical trials were conducted, 186 "Phase 2" clinical trials and 231 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 48 trials that are defined as “Not Applicable".

Azienda Ospedaliera Citta della Salute e della Scienza di Torino has several departments that took part in Clinical trials: "Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia" - 7 trials